Navigation Links
Access Pharmaceuticals Provides Update on ProLindac(TM)Clinical Development Plan
Date:9/10/2009

imaging.cancer.gov/clinicaltrials/imaging/" target="_new">RECIST criteria. No patient in any dose group exhibited any signs of acute neurotoxicity, which is a major adverse side-effect of the approved DACH platinum, Eloxatin, and ProLindac was well tolerated overall.

The recent Phase 2 recurrent ovarian study explored three different dose levels and two dosing regimens of ProLindac as a monotherapy treatment for advanced ovarian cancer, to provide data on the monotherapy anticancer activity and safety of ProLindac. Of patients eligible for evaluation according to standard RECIST criteria, clinically-meaningful disease stabilization was achieved in 42% of all patients, and 66% of all patients in the higher dose groups. Sustained and significant reductions in Ca-125, the established specific serum marker for ovarian cancer, were also observed in several patients.

"Access is extremely pleased with the clinical progress to date, and look forward to initiation of clinical trials looking at ProLindac in combination with commonly used chemotherapies," stated Jeffrey Davis, President & CEO. "Our partners in the Far East hosted Access together with key opinion leaders in oncology indications to discuss various potential protocol options, and hope to start enrolling patients in up to three combination trials by the end of the year, depending upon regulatory approvals of the trial protocols and certain other matters."

About ProLindac(TM):

ProLindac is a novel DACH platinum prodrug which has been shown to be active in a wide variety of solid tumors in both preclinical models and in human trials. Access believes that ProLindac's unique molecular design potentially could eliminate some of the toxic side effects seen in the currently marketed DACH platinum, Eloxatin, which has sales in excess of $2 billion.
'/>"/>

SOURCE Access Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Access Pharmaceuticals to Present at the Rodman & Renshaw Annual Healthcare Conference
2. NuAire Laboratory Economic Stimulus Package -- Free Accessories or Factory Options
3. One of the Nation's Leading Analytical Testing Laboratories is Now Easier to Access -- Pace Analytical Launches New Web Site to Showcase Its Three Business Divisions
4. Understanding Managed Markets: Effective Market Research Structures & Activities to Maximize Payer Access & Insights
5. Access Pharmaceuticals CEO Interviewed on Financial Website
6. Access Pharmaceuticals Announces Granting of Two US Patents for MuGard(TM)
7. FDA Clears Boston Scientifics SpyScope(R) Access and Delivery Catheter for Use in Endoscopic Procedures Throughout Pancreatico-Biliary System
8. Reorganizational Healing Provides Access to Greater Quality of Life, Reduced Stress
9. Solvay Pharmaceuticals Announces Strategic Partnership With HUYA to Access new Drug Candidates From China
10. Cyprotex Launches Cloe(R) Gateway, its Secure web Portal for Access to Cyprotex Services Including an Enhanced Version of Cloe(R) PK.
11. Ochsner and LSUHSC Partner to Provide Better Local Access to Comprehensive Cancer Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2014)... Sleep disturbances such as insomnia, hypersomnia, ... depression. According to a study published by the ... of depressed patients have insomnia symptoms, and hypersomnia ... adults and 10% of older patients, with a ... have a major impact on quality of life, ...
(Date:7/18/2014)... 2014  Neogen Corporation (Nasdaq: NEOG ) ... operating officer and president, has resigned, effective July 31, ... consultant going forward on special projects. His resignation is ... this position since September 2013. On an interim basis, ... , who has been Neogen,s chief executive officer since ...
(Date:7/18/2014)... 18, 2014 Global biotechnology company ... offices in Cambridge, MA, announces the launch of ... Software product that leverages the power of Next ... MiSeq sequencing platform. The assay and software have ... of Philadelphia (CHOP) and will include a new ...
(Date:7/18/2014)... MA (PRWEB) July 18, 2014 Provia ... to its growing Advisory Board. Dr. Vaught has ... for over 20 years. As one of the ... Biological and Environmental Repositories - in 1999, he served ... is again president-elect. , In 2005, Dr. Vaught began ...
Breaking Biology Technology:Open Label Data on Enhanced Sleep Released by JayMac Pharmaceuticals, LLC 2Open Label Data on Enhanced Sleep Released by JayMac Pharmaceuticals, LLC 3Omixon Launches Holotype HLA for NGS-based HLA Genotyping 2Omixon Launches Holotype HLA for NGS-based HLA Genotyping 3Dr. Jim Vaught, Ph.D., Former Chief of BBRB, Joins Provia Laboratories as Advisory Board Member 2Dr. Jim Vaught, Ph.D., Former Chief of BBRB, Joins Provia Laboratories as Advisory Board Member 3
... TORONTO, Sept. 20 /PRNewswire-FirstCall/ - Spectral Diagnostics Inc.,(TSX:SDI) ... Endotoxin,Activity Assay, a rapid diagnostic product for sepsis, ... division of the Italian,Menarini Group. Sepsis is the ... 60,000 victims each year. The treatment of severe ...
... Zentaris Inc.,(TSX: AEZ; Nasdaq: AEZS), a global biopharmaceutical company ... President and CEO,David J. Mazzo, Ph.D., will present a ... Thursday, September 27, 2007 at 10:00 a.m.,Eastern, in the ... York City. A live webcast of this presentation ...
... Sept. 20 ADVENTRX Pharmaceuticals,Inc. (Amex: ANX ... commercializing proprietary product candidates for the treatment,of cancer ... Levine,ADVENTRX,s chief executive officer, is scheduled to present ... September 27th, 2007 at 8:00 a.m.,Eastern Time. The ...
Cached Biology Technology:Spectral partner launches EAA(TM) Rapid Sepsis Diagnostic in Germany 2ADVENTRX Pharmaceuticals to Present at the 2007 UBS Global Life Sciences Conference 2
(Date:7/21/2014)... there are reasons mammoths and mastodons could have been ... research from the University of Cincinnati, the famously fuzzy ... before it was trendy at the end of ... Crowley, an assistant professor of geology and anthropology, shows ... likely were year-round residents and not nomadic migrants as ...
(Date:7/21/2014)... water and save on your utility bill? A paper ... the current issue of the journal Environment ... Effective Actions U.S. Households Can Take to Curb Water ... by simple actions such as installing more efficient appliances ... suggestions may be familiar, the researchers are the first ...
(Date:7/21/2014)... Medicine-led study suggests that parents of obese children often ... childhood weight gain or the importance of daily physical ... , The study is published online in the ... , "Parents have a hard time changing their child,s ... Rhee, MD, and an assistant adjunct professor in the ...
Breaking Biology News(10 mins):Mammoth and mastodon behavior was less roam, more stay at home 2Mammoth and mastodon behavior was less roam, more stay at home 3Researchers provide guide to household water conservation 2Researchers provide guide to household water conservation 3Parents rank their obese children as 'very healthy' 2
... Homeland Security announced the creation of five new ... Centers will study border security and immigration; explosives ... security; natural disasters, coastal infrastructure and emergency management; ... Center for Southeastern Tropical Advanced Remote Sensing (CSTARS) ...
... production must increase by more than 10 percent each ... energy demands and replace fossil fuels, but this is ... Inderscience,s International Journal of Nuclear Governance, Economy and Ecology ... improvement in nuclear power efficiency otherwise each new power ...
... dietary supplement called NutraStem has been shown to ... product, NutraStem also known as NT-020, is a ... carnosine extracts- a combination of nutritional ingredients thought to ... is the third leading cause of death and the ...
Cached Biology News:CSTARS to form part of Department of Homeland Security's Center of Excellence for Maritime Security 2Nuclear cannibals 2Blueberry and green tea containing supplement protects against stroke damage 2
Guanylate Kinase Purified Anti-Mouse, Anti-Rat clone 28, Isotype Mouse IgG 1 , 50 µg Consult technical datasheet for details....
... H2OBIT is a fully licensed, high throughput, water ... of up to 24 microplates. This equates to ... ,A robotic arm rapidly transfers a basket ... temperature ramping times that are considerably faster than ...
... used gasketed gel trays. Turn the tray 90 degrees ... back and run the gel - its as simple ... tray is UV transparent. Each tray accommodates two comb ... one in the center. This allows you the option ...
Porcine Pulmonary Artery Endothelial Cells (PPAEC) (>500,000 cells)...
Biology Products: